Fig. 2
From: The value of acetylation reader YEATS2 in hepatocellular carcinoma management
YEATS2 Expression Analysis in HCC Patient Cohorts. (A, B) Differential YEATS2 expression across age groups in TCGA and HCC datasets. (C-E) YEATS2 expression analysis stratified by disease stages in TCGA and HCC datasets. (F) Expression variations in tumor status. (G) Expression changes across histologic grades. (H, I) Differential analysis of YEATS2 across AFP levels in two HCC datasets.
